News
News
Meet the IFIGENEIA partner: Cosylab, d. d., Control System Laboratory
Cosylab d.d. supports cutting-edge accelerator-based technologies worldwide—from Big Science facilities to advanced medical applications—and brings this same end-to-end expertise to IFIGENEIA’s work on radioisotope production and radiopharmaceuticals. Cosylab d.d. is...
Sarajevo 2026: 10 Days of CBI Training for Students – Apply Now
IFIGENEIA is proud to be an organiser of a ten-day event, a challenge based on innovations for students - CBI, that will be held at the University of Sarajevo. The goal is to present an innovative idea on the use of accelerators in applications that benefit the wider...
IFIGENEIA: Help Shape the Future of Nuclear Medicine and Take Part in Our Hospital Survey!
The IFIGENEIA project (Horizon Europe, WIDERA) aims to lay the foundations for significant advancements in the production and clinical application of radionuclides using linear accelerators (LINACs), thereby enhancing radiopharmaceutical development and availability...
Meet the IFIGENEIA partner: BIOKOSMOS S.A.
BIOKOSMOS MEDICAL SCIENTIFIC EQUIPMENT COMMERCIAL INDUSTRY SOCIETE ANONYME, (BIOKOSMOS SA, a pioneering Greek company in the field of radiopharmaceuticals and molecular imaging, brings decades of expertise, advanced technological infrastructure, and strong research...
Meet the IFIGENEIA partner: University of Cyprus (UCY)
The University of Cyprus (UCY) is a major academic and research institution in the Eastern Mediterranean region, with a strong strategic role in advancing education, training, and capacity building within the IFIGENEIA project. Through its established excellence in...
Meet the IFIGENEIA partner: Jožef Stefan Institute
Jožef Stefan Institute as Slovenia’s Leading Research Institution The Jožef Stefan Institute is Slovenia’s leading scientific research institute dedicated to science and technology, covering a broad spectrum of basic and applied research. With strong international...
Analysis of cancer clinical trials shows disparities on several fields
In September 2025 World Health Organization (WHO) published results of an extensive analysis, Cancer research and development landscape: overview of 1999-2022 period. The report presents interesting insights and findings for cancer treatment, based on 112 899...
From Physics to Clinics: A Journey through Science and Medicine at SSST
The Sarajevo Medical School of the University Sarajevo School of Science and Technology (SSST) recently had the honour of hosting Dr. Yiota Foka, senior scientist at the GSI Helmholtz Centre for Heavy Ion Research in Darmstadt and CERN collaborator, for an inspiring...
Meet the IFIGENEIA partner: Region of Central Macedonia
As a key public authority in Northern Greece, the Region of Central Macedonia contributes strategic insight and regional expertise to support the sustainability and long-term impact of the IFIGENEIA project. The Region of Central Macedonia (RCM) is one of the thirteen...
UNSA hosts IFIGENEIA: Mentoring Event and Rector Support
IFIGENEIA mentoring event at the UNSA Department of PhysicsA special interactive event, within the IFIGENEIA mentoring scheme, was organized for students of the Department of Physics at the University of Sarajevo, on October 10th 2025. The event was based on the...
Meet the IFIGENEIA partner: RTD Talos Limited
With strong experience at the intersection of policy, innovation, and business development, RTD Talos contributes essential expertise to strengthening the long-term impact and sustainability of the IFIGENEIA project. RTD Talos was established in September 2000, at a...
ESRR 2026, European society of radiopharmacy and radiochemistry
The 22nd European Symposium on Radiopharmacy and Radiochemistry (ESRR 2026) will be held in Bergen, Norway, on 16–19 April 2026. The symposium focuses on radionuclide production, radiochemistry, radiopharmaceutical development, radiobiology, and clinical translation....